Canada markets closed

Can-Fite BioPharma Ltd. (CANF)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
2.3800+0.1426 (+6.37%)
At close: 04:00PM EDT
2.4100 +0.03 (+1.26%)
After hours: 05:19PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 10.53M
Enterprise Value 1.65M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)13.65
Price/Book (mrq)1.90
Enterprise Value/Revenue 2.22
Enterprise Value/EBITDA 0.22

Trading Information

Stock Price History

Beta (5Y Monthly) 0.91
52-Week Change 30.00%
S&P500 52-Week Change 326.49%
52 Week High 33.3300
52 Week Low 31.8100
50-Day Moving Average 32.1470
200-Day Moving Average 32.2431

Share Statistics

Avg Vol (3 month) 320.55k
Avg Vol (10 day) 331.57k
Shares Outstanding 54.99M
Implied Shares Outstanding 64.08M
Float 81.38B
% Held by Insiders 10.00%
% Held by Institutions 19.57%
Shares Short (Apr 30, 2024) 49.93k
Short Ratio (Apr 30, 2024) 40.46
Short % of Float (Apr 30, 2024) 4N/A
Short % of Shares Outstanding (Apr 30, 2024) 40.18%
Shares Short (prior month Mar 28, 2024) 47.46k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3May 10, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Jan 09, 2023

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,183.23%

Management Effectiveness

Return on Assets (ttm)-53.15%
Return on Equity (ttm)-142.49%

Income Statement

Revenue (ttm)743k
Revenue Per Share (ttm)0.30
Quarterly Revenue Growth (yoy)-21.30%
Gross Profit (ttm)N/A
EBITDA -8.18M
Net Income Avi to Common (ttm)-7.63M
Diluted EPS (ttm)-3.0000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)8.92M
Total Cash Per Share (mrq)0.01
Total Debt (mrq)40k
Total Debt/Equity (mrq)0.64%
Current Ratio (mrq)4.91
Book Value Per Share (mrq)0.00

Cash Flow Statement

Operating Cash Flow (ttm)-8.44M
Levered Free Cash Flow (ttm)-5.12M